Search Results 101-110 of 18305 for total bilirubin

  1. Study Of Endocrine Therapy With Or Without Abemaciclib (LY2835219) Following Surgery In Participants With Breast Cancer - Mayo Clinic

    Total bilirubin ≤ 1.5 × ULN. Patients with Gilbert's syndrome with a total bilirubin ≤ 2.0 times ULN and direct bilirubin within normal limits are permitted.

  2. A Study Of NST-6179 In Subjects With Intestinal Failure-Associated Liver Disease (IFALD). - Mayo Clinic

    Total bilirubin ≤2.5 mg/dL in the absence of Gilbert's Syndrome. 3. Serum albumin ≥2.5 g/dL; 4. International normalized ratio (INR) ≤1.3 in the absence ...

  3. Cisplatin, Intensity-Modulated Radiation Therapy, And Pembrolizumab In Treating Patients With Stage III-IV Head And Neck Squamous Cell Carcinoma - Mayo Clinic

    Serum total bilirubin: =< 1.5 X ULN OR; Direct bilirubin: =< ULN for patients with total bilirubin levels > 1.5 ULN; Aspartate aminotransferase (AST) (serum ...

  4. A Phase 1/2a Dose-Finding Study Of PT-112 In Patients With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    Total bilirubin ≤ 1.5 x ULN or direct bilirubin ≤ 1.5 x ULN when total bilirubin is > 1.5 x ULN;; Calculated creatinine clearance (CrCl) ≥ 30 mL/min ...

  5. A Study To Evaluate Ribociclib Plus Letrozole To Treat Cancer Of The Ovary, Fallopian Tube Or Peritoneum - Mayo Clinic

    Total bilirubin < ULN or total bilirubin ≤ 3.0 x ULN or direct bilirubin ≤ 1.5 x ULN in patients with well-documented Gilbert's Syndrome. Patient with ...

  6. A Study To Evaluate MUC1 Vaccine To Prevent Lung Cancer In Current And Former Smokers At High Risk For Lung Cancer - Mayo Clinic

    ... Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) Note: Higher total bilirubin levels (=< 3 mg/dL) can be allowed if due to known benign ...

  7. Bridge To HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior To Liver Transplantation - Mayo Clinic

    Terminal total bilirubin 2-4 mg/dl. Donation after Brain Death (DBD) Liver Exclusion Criteria (one or more):. Donor age < 18 or > 85 years. Anticipated cold ...

  8. A Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors - Mayo Clinic

    Total bilirubin ≤ 1.5x institutional ULN (except participants with Gilbert's Syndrome who must have normal direct bilirubin); Serum creatinine ≤ 1.5x ULN ...

  9. A Study to Evaluate Hepatotoxicity Risk Associated with TURALIO™ (pexidartinib) Treatment - Mayo Clinic

    AST or ALT > 3 × ULN with concurrent total bilirubin > 2 × ULN;; Isolated total bilirubin > 2 × ULN (excluding patients with Gilbert's syndrome);; Isolated ...

  10. A Study To Evaluate Pembrolizumab And Dasatinib, Imatinib Mesylate, Or Nilotinib In Treating Patients With Chronic Myeloid Leukemia And Persistently- Detectable Minimal Residual Disease - Mayo Clinic

    Serum total bilirubin ≤ 1.5 X ULN OR Direct bilirubin ≤ ULN for subjects with total bilirubin levels > 1.5 X ULN. Bilirubin: ______ Institutional ULN ...